Researchers found that certain fungal species in tumors are linked to inflammation and reduced cell-to-cell adhesion, features associated with late-stage cancer spread. High levels of these fungi may serve as biomarkers for metastasis risk and lead to more effective treatment choices.
A UTHealth Houston study found regional disparities in cancer screening rates tied to social vulnerability, with lower rates in more vulnerable counties. The study analyzed 3,141 US counties and discovered significant differences in breast, cervical, and colorectal cancer screenings.
A study of 3,141 US counties found that counties with higher social vulnerability had lower rates of recommended breast, cervical, and colorectal cancer screenings. The findings suggest that addressing social determinants of health may be crucial for improving cancer screening rates.
The TTUHSC team will provide no-cost colorectal cancer screening and colonoscopies to underinsured and uninsured people living in South Plains region counties. The FIT-STOP program aims to find signs of early-stage colorectal cancer to prevent treatment needs, leveraging existing relationships with partners.
A new predictive biomarker, RNF43 mutations, has been identified as a significant predictor of response to anti-BRAF/EGFR combinatory therapy in patients with microsatellite stable BRAF V600E metastatic colorectal cancer. This biomarker is associated with improved progression-free and overall survival rates.
A cohort study found that endoscopists performing colonoscopies in FIT-based screening programs should aim for markedly higher ADRs compared to primary colonoscopy screening. The study suggests that high ADRs are associated with lower colorectal cancer incidence and mortality. Researchers recommend using ADR targets, including differen...
The author suggests that individuals at average risk between 45 and 49 years old should consider non-invasive screening alternatives, such as fecal immunochemical tests or stool DNA testing. This approach would benefit others who need more invasive screening resources and reduce the strain on colonoscopy services.
In a Phase I/II trial, selpercatinib demonstrated a 44% objective response rate across multiple tumor types, including pancreatic and colorectal cancers. The study found responses regardless of cancer type or prior treatment history, confirming RET fusions as a tissue-agnostic target.
A new combination immunotherapy regimen shows remarkable activity in metastatic colorectal cancer patients without liver metastases, achieving a response rate of 40% and median overall survival exceeding 20 months. The study's findings confirm the importance of the tumor microenvironment in shaping the response to immunotherapy.
Researchers found a strong association between high ultra-processed food consumption and colorectal cancer risk in men, particularly those consuming processed meats. In contrast, no link was found for women, suggesting potential sex differences in the relationship between diet and cancer risk.
Two large studies found a link between high consumption of ultra-processed foods and increased risks of cardiovascular disease, bowel cancer, and death. The findings support policies limiting ultra-processed foods and promote eating unprocessed or minimally-processed foods for improved public health.
Researchers developed an algorithm to identify different regions within tumors using nearly 6,500 digital slide images. The algorithm can predict recurrence-free survival and help guide therapy for patients with colon cancer.
Researchers at Queen Mary University of London have found that increasing the blood level at which faecal blood testing triggers a colonoscopy invitation can reduce lives lost from bowel cancer. This approach is more effective than changing the gap between screening invitations.
A study led by Toho University identified a glycan structure, Lewis glycans, on the cell surface that makes cancer cells vulnerable to TRAIL-induced death. Cancer cells highly expressing this structure are more sensitive to TRAIL therapy and can serve as a predictive biomarker.
Researchers found that using the drug erlotinib, which blocks a specific cancer pathway, led to a 30 percent reduction in polyps formed in patients with FAP. The study's findings suggest potential ways to prevent colorectal cancer in the general population at an earlier stage.
A new UCI-led study reveals that the circadian clock's disruption can drive colorectal cancer progression through genetic mutations and increased tumor growth. The study found that both environmental and genetic disruptions of the circadian clock contribute to APC loss of heterozygosity, a critical factor in CRC development.
A recent clinical trial led by Massachusetts General Hospital validated a strategy for increasing shared decision-making about colorectal cancer screening in older patients. Brief physician training plus reminders resulted in patients reporting higher quality conversations, with more discussing their preferences and having more options...
A new study by Tokyo University of Science researchers reveals that dendritic cell immunoreceptor (DCIR) plays a crucial role in the development of colorectal tumors. Blocking DCIR may prevent ulcerative colitis and colon cancer, offering a potential therapeutic target for treating these diseases.
Researchers investigated the effects of neoadjuvant chemoradiotherapy on CD8+ tumor-infiltrating lymphocytes, PD-L1, and mucin expression in rectal cancer patients. The study found that nCRT exposure was associated with higher mucin expression and a non-significant difference in PD-L1 expression, suggesting an immunosuppressive phenotype.
A new study from Duke University suggests that consuming more fiber can lead to improved gut health, regardless of the specific supplement used. Participants who had been eating the least amount of fiber before the study showed the greatest benefit from supplements.
Research reveals T cells in colorectal cancer have a double-edged function. Initially protective against tumor growth, they later promote cancer progression by altering their receptors and producing pro-inflammatory cytokines. The study offers new insights into the role of T cells in colorectal cancer and potential avenues for therapy.
Scientists from A*STAR and NUS Cancer Science Institute identified a key cancer progression mechanism that could lead to more effective treatments. The discovery involves reactivating the hTERT gene, which is responsible for prolonging telomeres in cancer cells.
Researchers at Johns Hopkins Medicine found that Clostridioides difficile (C. difficile) bacteria may cause colorectal cancer in younger adults. The bacterium causes serious diarrheal infections and is linked to approximately 500,000 infections annually in the US.
Researchers developed an AI system that classifies IBDN lesions accurately, displaying image-based diagnostic ability with 64.5% sensitivity and 89.5% specificity. The correct diagnosis rate of the AI system was 79.0, surpassing that of endoscopists, who achieved a 77.8% accuracy rate.
A systematic review and meta-analysis of 39 publications found a global association between COVID-19 measures and reduced breast, colorectal, and cervical cancer screenings. This could lead to an increase in avoidable cancer deaths.
A new classification system for colorectal cancer has been proposed, grouping cancers into five subtypes based on epithelial status, microsatellite status, and fibrosis. This update could inform targeted drug development efforts and improve treatment approaches for patients with different biological characteristics.
A study found that younger U.S. adults are less likely to be screened for colorectal cancer despite being eligible under new guidelines, with greater disparities observed across race, ethnicity, income, education, and insurance coverage. Screening participation increased over time but was smallest among individuals age 50-54.
Researchers found eligible younger Americans (45-54) are less likely to meet recommended colorectal cancer screening guidelines due to work, family, insurance, and healthcare barriers. These disparities may worsen as the age group is expanded under new USPSTF recommendations.
Researchers found high mortality rates in the Midwest/northeastern Great Lakes region and lower risk counties in western/southwestern areas. The study highlights regions warranting further investigation and preventive interventions to address the increasing burden of young-onset colorectal cancer.
A recent survey revealed significant gaps in cancer screening among women aged 50-64, with rates as low as 50% for colorectal cancer and 46.5% for both cancers. The study found that patient-centered approaches to screening can facilitate timely testing and management of abnormal results.
Researchers analyzed data from over 134,000 participants and found a strong association between Western diets and colorectal tumors containing the pks+ E. coli bacteria. The study suggests that specific components of Western-style diets may increase the risk of colorectal cancer by promoting the growth of these pathogenic bacteria.
Researchers at Thomas Jefferson University have developed a new Listeria-based booster that improves the protection of vaccines against recurring colon cancer. The combination of viral and bacterial vaccine approaches shows safe and far more effective results than either approach alone.
A new study led by UCSF found that routine screening for and removal of precancerous anal lesions can significantly reduce the risk of anal cancer. The study, known as ANCHOR Study, showed a 57% reduction in anal cancer among people with HIV who underwent treatment for high-grade squamous intraepithelial lesions (HSIL).
A recent study found that certain bacteria species in the gut are associated with a higher risk of colorectal cancer in younger populations. The research suggests that dietary patterns high in processed meats, low-calorie drinks, and liquor may contribute to this increased risk.
The American Gastroenterological Association has released a series of evidence-based position statements guiding the creation of a national colorectal cancer screening approach. The goal is to eliminate barriers and reduce mortality by ensuring equitable access to CRC screening programs for all individuals.
A recent study published in the New England Journal of Medicine found that dostarlimab was effective in treating a subtype of rectal cancer, showing remarkable responses and resolving difficult symptoms. The treatment offers a more effective and less toxic alternative to traditional chemotherapy and radiation.
A national survey study found that colorectal cancer screening increased via stool testing while colonoscopy decreased during the pandemic. Breast and cervical cancer screenings also saw modest declines.
A study by Cedars-Sinai researchers confirms that counting metastatic lymph nodes is a dominant predictor of cancer death, improving staging and treatment for solid tumors. The simple process can be applied in virtually all medical settings without increased cost or complexity.
A new large national study found Black patients with early-onset colorectal cancer received worse and less timely care than white counterparts. Health insurance coverage type was the largest identified contributor to racial disparities, accounting for 28.6% of the disparity among colon cancer patients.
The ECOG-ACRIN Cancer Research Group presented promising trial results at ASCO 2022, including an 8-year survival rate in the CHAARTED prostate trial. The research also explored outcomes by tobacco use in head and neck studies, shedding light on cancer treatment effectiveness.
A study of early-onset colon cancer found that five-year survival rates remained lower for Blacks and Hispanics compared to Whites, despite improvements in White survival over a 20-year span. The disparities persisted even among younger adults with localized disease.
Research found a significant increase in esophageal cancer and Barrett's esophagus among middle-aged adults, with rates nearly doubling between 2012 and 2019. The study suggests an urgent need for earlier endoscopic screening in this age group, particularly those with multiple risk factors.
A new study has identified persistent racial and ethnic disparities in five-year survival rates for younger adults with colorectal cancer. White patients had a higher five-year relative survival rate compared to Black, Hispanic, and Asian patients, regardless of disease stage.
Adults aged 45-64 experienced a nearly doubled rate of esophageal cancer and a 50% increase in Barrett's esophagus between 2012 and 2019. Researchers recommend more frequent screening for middle-aged patients with multiple risk factors.
Chronic bacterial infections can lead to chronic inflammation and DNA damage, increasing CRC risk. Salmonella infections are particularly risky, as they impair immune responses and promote tumorigenesis.
A new study from Massachusetts General Hospital found that starting endoscopic screening at age 45 can significantly reduce the risk of colorectal cancer (CRC) in women. The study included 111,801 women and showed a 50-60% lower risk of CRC among those who started screening at this age.
Initiation of lower gastrointestinal endoscopy before age 50 among women is associated with a reduced risk of colorectal cancer. Guidelines now recommend that women initiate colorectal cancer screening before age 50 to reduce the risk, including cases diagnosed before age 55.
Canada's cancer rates are declining overall, but new cases and deaths are on the rise due to an aging population and growing numbers. Despite this, efforts in cancer prevention, screening, early detection, and treatment have led to improved survival rates for those diagnosed with cancer.
Researchers found that a molecule called beta-hydroxybutyrate (BHB) produced in the liver during low-carb diets can suppress colorectal tumor growth. BHB's anti-tumor effects were replicated by giving mice the molecule directly, indicating its potential as a preventive and treatment for colorectal cancer.
The US Multisociety Task Force on Colorectal Cancer recommends genetic evaluation and personalized surveillance plans for patients with hamartomatous polyps. Genetic testing is critical in cancer prevention, allowing for tailored cancer surveillance to prevent progression and save lives.
The USPSTF recommends against initiating low-dose aspirin use for primary prevention of CVD in adults 60+, but suggests its use for those with a 10% or greater 10-year CVD risk. The net benefit is small, and those willing to take daily aspirin are more likely to benefit.
Researchers at Texas A&M University developed a low-cost, minimally invasive wireless device that uses photodynamic therapy to kill cancer cells. The device enables precise and safe treatment options during surgery, potentially reducing the need for additional treatments like chemotherapy.
A study published in Gastroenterology found that artificial intelligence reduced the rate of missed precancerous polyps in colorectal cancer screening by twofold compared to standard colonoscopy. The AI detection method identified smaller, flatter polyps and improved false negative rates.
Researchers identified rural Georgia counties with high mortality rates from breast, prostate, colorectal, and lung cancer. These hotspots were concentrated in the eastern Piedmont to southern Coastal Plain regions, as well as southwestern and northern rural areas.
Researchers used mathematical modeling to characterize the interplay between immune suppression, immune blockade and antigenicity in pre-cancerous cells. They found that an immunosuppressive environment is crucial for colorectal cancer progression.
A clinical trial reveals that lamivudine, a widely used HIV treatment, halted disease progression in 28% of patients with fourth-line metastatic colorectal cancer. The study suggests an unexpected promising direction for cancer treatment and encourages the exploration of pairing reverse transcriptase inhibitor therapy with immunotherapy.
Researchers found that modeling studies have been assuming colonoscopies are more accurate than they really are, detecting fewer small adenomas. However, colonoscopy still appears effective in finding precursors of cancer.
The study reveals a narrowing gap between cancer profiles in China and the USA, with converging trends in lung, breast, and colorectal cancers. China's cancer burden is expected to rise, while the US has seen reduced rates since the 1990s due to effective prevention strategies.
A machine-learning algorithm detected potential signs of colorectal cancer in high-risk patients who missed routine screenings. The algorithm identified patients as high-risk by analyzing age, gender, and recent CBC results, and subsequent screenings showed significant findings in 70% of the flagged group.
Researchers develop innovative non-contact agitation technology to assess motility and invasive capacity of cancer cells in tissue sections. The study reveals significant increases in Rac/Cdc42 activity in tumor areas, with stronger correlations found in advanced cancer stages.